Atypical Psychedelic & Typical Psychedelics - Haley Dourron

Pharmacological differences between 5-MeO-DMT and typical psychedelics such as psilocybin or DMT center on receptor selectivity and physiological risks. Unlike classic 5-HT2A agonists, 5-MeO-DMT exhibits approximately 108-fold greater selectivity for 5-HT1A receptors, which alters its neurochemical and subjective impact. Phenomenologically, 5-MeO-DMT experiences often present as a 'white-out' state or profound void accompanied by amnesia, contrasting with the detailed visual hallucinations typical of N,N-DMT. Clinical data and case reports also reveal potential risks, including seizure-like activity, respiratory arrest, and persistent reactivations after use. Qualitative research into individuals with psychotic disorders indicates that while classic psychedelics can sometimes offer therapeutic insight, rigorous safety protocols are necessary given the unique risks and mechanisms of atypical psychedelics.